Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 11/20 | 0.68 |
| ▸ | PTPN2 | P17706 | 6/20 | 0.68 |
| ▸ | POLB | P06746 | 3/20 | 0.68 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.68 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.68 |
| ▸ | F3 | P13726 | 3/20 | 0.68 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.68 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.68 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.68 |
| ▸ | PTPRC | P08575 | 2/20 | 0.68 |
| ▸ | PTPRF | P10586 | 2/20 | 0.68 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.68 |
| ▸ | CES1 | P23141 | 2/20 | 0.68 |
| ▸ | ACP1 | P24666 | 2/20 | 0.68 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.68 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.68 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.68 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.68 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.68 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5799296 | 0.87 | PTPN1 (0.73) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL2586364 | 0.87 | PTPN1 (0.73) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL381229 | 0.86 | PTPN1 (0.69) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL12274498 | 0.84 | PTPN1 (0.71) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL5795816 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL5799434 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL5799378 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| Gypsogenin SCHEMBL29722834 | 0.82 | PTPN1 (0.83) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| SCHEMBL5797472 | 0.82 | PTPN1 (0.72) | PTPN1PTPN2POLBAKR1B10GPBAR1 | |
| Oleanolic_Acid SCHEMBL13728119 | 0.81 | PTPN1 (0.96) | PTPN1PTPN2POLBAKR1B10GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116942708-A | Processing method of fresh Phellinus linteus | 南阳师范学院 | 2023-10-27 | — | — | CN | claimed |
| EP-2012795-A4 | THERAPEUTIC TRITERPENOIDS | UNIV MINNESOTA (US) | 2009-07-22 | — | — | EP | claimed |
| US-20090136566-A1 | THERAPEUTIC TRITERPENOIDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2009-05-28 | — | — | US | claimed |
| EP-2012795-A2 | THERAPEUTIC TRITERPENOIDS | Regents of the University of Minnesota (US) | 2009-01-14 | — | — | EP | claimed |
| WO-2007121352-A2 | THERAPEUTIC TRITERPENOIDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-10-25 | — | — | WO | claimed |
| CN-116942708-A | Processing method of fresh Phellinus linteus | 南阳师范学院 | 2023-10-27 | — | — | CN | disclosed |
| EP-2823819-B1 | OLEANOLIC ACID ACETATE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING TLR- OR IL-6-MEDIATED DISEASES | KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY (KR) | 2021-06-02 | — | — | EP | disclosed |
| US-20110218143-A1 | COMPOSITIONS AND METHODS FOR TISSUE REPAIR | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2011-09-08 | — | — | US | disclosed |
| CN-101810686-A | Compatible composition for treating rheumatoid arthritis and preparation method thereof | NINGBO LIWAH PLANT | 2010-08-25 | — | — | CN | disclosed |
| EP-2012795-A4 | THERAPEUTIC TRITERPENOIDS | UNIV MINNESOTA (US) | 2009-07-22 | — | — | EP | disclosed |
| US-20090136566-A1 | THERAPEUTIC TRITERPENOIDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2009-05-28 | — | — | US | disclosed |
| EP-2012795-A2 | THERAPEUTIC TRITERPENOIDS | Regents of the University of Minnesota (US) | 2009-01-14 | — | — | EP | disclosed |
| WO-2007121352-A2 | THERAPEUTIC TRITERPENOIDS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090136566-A1 | THERAPEUTIC TRITERPENOIDS | EBP, PGGT1B, LIPC | PTPN1 3600/4885PTPN2 2899/4885POLB 1710/4885 |
| US-20110218143-A1 | COMPOSITIONS AND METHODS FOR TISSUE REPAIR | CD68, TNNC1, MATR3 | PTPN1 2626/4885PTPN2 2565/4885POLB 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.